CHICAGO, March 18, 2019 /PRNewswire/ -- rMark Bio announces the launch of Fabric™, an advanced end-to-end AI solution thatdelivers personalized business intelligence through integrated applications and API accessible services that are built to solve common scientific and business challenges within life sciences organizations.
"While AI and machine learning hold
Fabric is designed to analyze petabytes of unstructured text, videos, voice, proteomics, genomic and free form data from existing business applications such as Microsoft™, Salesforce™ and Veeva™ along with third party data sources from IQVIA™ and Symphony Heath™. Working in unison, Fabric's neural networks determine the most relevant insights and discoveries and then shape them based on each department or user's specific business needs without the requirement of multiple systems.
Fabric can be tailored to address issues faced by specific divisions across an organization. Life sciences companies can utilize Fabric's agility in a variety of ways. Customers use Fabric's data service to enrich their data with public sources, automating quality control and preparing it for machine learning. Other customers leverage Fabric ML's data intelligence to build new insights and shape them into business decisions or recommendations.
"rMark Bio offers companies myriad ways to partner, build and collaborate with us to empower transformation across multiple departments," said Smith.
Today, customers adopt Fabric offerings in a multitude of ways, for example:
"Fabric APIs are designed specifically with life sciences companies in mind. Our strategy is to enable these companies and their teams to benefit from Fabric's ML without always needing to incorporate another app into their workflow," said Annette Thurston, vice president of product for rMark Bio. "By delivering intelligence via products that teams already use – be it chat, email, a CRM, voice or others – we can surface the right insights at the right time within the products they use most frequently. For those who require an app, we offer an out of the box solution, but Fabric Services also solves a real issue in digital transformation as a whole — app overload, which can lead to lack of engagement and decreased productivity."
rMark Bio has opened Fabric to select product companies to build and sell their own offerings for the life sciences industry. OpX Insights built its flagship product VoKOL™ using Fabric's NLP services and Field Insights APIs, which enhances the ability of medical affairs to capture and report on scientific insights from field teams. VoKOL optimizes scientific exchange by collecting current strategies in one place, enabling a quick dive into individual strategies for reporting, trending and analysis and then providing intelligent alerts based on field insights.
"Fabric enabled us to rapidly develop a solution that helps analyze insights, identify new strategies and transform data into actionable tactics for medical professionals," said Mike Abbadessa, PharmD, CEO and Founder of OpX Insights. "Building on this industry-leading solution meant we could accelerate our time to market."
Abbadessa of OpX Insights will be joining rMark Bio for a live demo of VoKOL and Fabric at booth 307 at the DIA Medical Affairs and Scientific Communications Forum March 18-20 in Orlando, Fla.
About rMark BiorMark Bio, Inc. was created to transform the life sciences and pharmaceutical industries by making artificial intelligence simple to adopt, easy to use and continuously transformative through a holistic approach incorporating strategy, technology and people power. Founded in 2015 by Jason M. Smith, CEO, and Lev Becker, Ph.D., Chief Scientist, rMark Bio is based in Chicago and Seattle. rMark Bio provides services to the top 20 pharmaceutical companies globally and has partnered with industry-leading technology and health care organizations, including Microsoft, nVidia, Apigee/Google, and MATTER.
View original content:http://www.prnewswire.com/news-releases/rmark-bios-fabric-scalable-ai-solution-helps-life-sciences-companies-accelerate-drug-discovery-collaboration-and-development-300813958.html
SOURCE rMark Bio Inc.
Subscribe to our Free Newsletters!